These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 27544484)

  • 21. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.
    Devi L; Tang J; Ohno M
    Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice.
    Farfara D; Sooliman M; Avrahami L; Royal TG; Amram S; Rozenstein-Tsalkovich L; Trudler D; Blanga-Kanfi S; Eldar-Finkelman H; Pahnke J; Rosenmann H; Frenkel D
    J Neuroinflammation; 2023 Jul; 20(1):174. PubMed ID: 37496076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease.
    Davis N; Mota BC; Stead L; Palmer EOC; Lombardero L; Rodríguez-Puertas R; de Paola V; Barnes SJ; Sastre M
    J Neuroinflammation; 2021 Mar; 18(1):73. PubMed ID: 33731156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
    Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
    Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
    Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
    Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
    Wu PJ; Hung YF; Liu HY; Hsueh YP
    Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 29. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
    Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
    J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
    Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
    J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.
    Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Burchett JM; Schuler DR; Cirrito JR; Diwan A; Lee JM
    J Neurosci; 2014 Jul; 34(29):9607-20. PubMed ID: 25031402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental enrichment reverses Aβ pathology during pregnancy in a mouse model of Alzheimer's disease.
    Ziegler-Waldkirch S; Marksteiner K; Stoll J; d'Errico P; Friesen M; Eiler D; Neudel L; Sturn V; Opper I; Datta M; Prinz M; Meyer-Luehmann M
    Acta Neuropathol Commun; 2018 May; 6(1):44. PubMed ID: 29855361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model.
    Daschil N; Obermair GJ; Flucher BE; Stefanova N; Hutter-Paier B; Windisch M; Humpel C; Marksteiner J
    J Alzheimers Dis; 2013; 37(2):439-51. PubMed ID: 23948887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
    Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
    J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides.
    Zhou J; Singh N; Galske J; Hudobenko J; Hu X; Yan R
    Mol Neurodegener; 2023 May; 18(1):31. PubMed ID: 37143090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
    Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
    Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.